Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2019
vol. 121 abstract:
Review paper
The Current Knowledge on Navigated Retinal Laser Therapy (Navilas)
Ewelina Lachowicz
1
,
Wojciech Lubiński
1
Online publish date: 2020/03/31
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Digital systems supporting laser therapy enabled the introduction of new quality �navigated laser therapy for the treatment of retinal diseases. Navilas is the first and so far the only camera in the world that uses this technology and allows for standardized management. The used wavelength (577 nm �yellow) is currently recommended for retinal diseases treatment. The microsecond pulse mode additionally gives the possibility of the therapy of subfoveal and peri-foveal lesions. By using the innovative technology Navilas significantly exceeds conventional laser therapy. The system offers high precision and long-lasting satisfactory therapeutic effect with an increased level of safety. Navigated retinal laser therapy was used till now in: the central retinal vein or its branches occlusion, proliferative diabetic retinopathy, diabetic macular edema, central serous chorioretinopathy, macroadenomas, retinal telangiectasias, polyploidal choroidal vasculopathy, and in case of peripheral changes. Navigated therapy has the potential possibility to replace traditional laser therapy in many retinal diseases.
keywords:
NAVILAS, navigated laser, yellow laser photocoagulation, microsecond laser therapy |
|